Switching from the bio-originators to biosimilar : is it premature to recommend this procedure?
| Errataetall: |
CommentOn: Ann Rheum Dis. 2018 Feb;77(2):165-174. - PMID 28866648 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:78 |
|---|---|
| Enthalten in: |
Annals of the rheumatic diseases - 78(2019), 4 vom: 01. Apr., Seite e23 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Cantini, Fabrizio [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Ankylosing spondylitis |
|---|
| Anmerkungen: |
Date Completed 30.12.2019 Date Revised 21.03.2022 published: Print-Electronic CommentOn: Ann Rheum Dis. 2018 Feb;77(2):165-174. - PMID 28866648 Citation Status MEDLINE |
|---|
| doi: |
10.1136/annrheumdis-2017-212820 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM279515812 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM279515812 | ||
| 003 | DE-627 | ||
| 005 | 20231225023138.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1136/annrheumdis-2017-212820 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0931.xml |
| 035 | |a (DE-627)NLM279515812 | ||
| 035 | |a (NLM)29288210 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Cantini, Fabrizio |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Switching from the bio-originators to biosimilar |b is it premature to recommend this procedure? |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 30.12.2019 | ||
| 500 | |a Date Revised 21.03.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentOn: Ann Rheum Dis. 2018 Feb;77(2):165-174. - PMID 28866648 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Comment | |
| 650 | 4 | |a ankylosing spondylitis | |
| 650 | 4 | |a anti-tnf | |
| 650 | 4 | |a psoriatic arthritis | |
| 650 | 4 | |a rheumatoid arthritis | |
| 650 | 4 | |a treatment | |
| 650 | 7 | |a Antirheumatic Agents |2 NLM | |
| 650 | 7 | |a Biosimilar Pharmaceuticals |2 NLM | |
| 700 | 1 | |a Benucci, Maurizio |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annals of the rheumatic diseases |d 1939 |g 78(2019), 4 vom: 01. Apr., Seite e23 |w (DE-627)NLM000174114 |x 1468-2060 |7 nnns |
| 773 | 1 | 8 | |g volume:78 |g year:2019 |g number:4 |g day:01 |g month:04 |g pages:e23 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1136/annrheumdis-2017-212820 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 78 |j 2019 |e 4 |b 01 |c 04 |h e23 | ||